Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer... ( Full spectrum of technologies sho...)

HOME >> BIOLOGY >> TECHNOLOGY

Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer Treatment

Date:9/22/2008

Full spectrum of technologies showcased at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Boston, September

21-24, 2008

BOSTON, Sept. 22 /PRNewswire-FirstCall/ -- ASTRO Booth # 547 -- Varian Medical Systems (NYSE: VAR), world leader in advanced radiotherapy solutions for treating cancer and other disorders, is showcasing a full spectrum of technologies and products for planning and delivering fast, precise cancer treatments at the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology in Boston this week. In addition, the Varian booth at ASTRO includes a glimpse into the company's vision of future technologies for managing cancer care from diagnosis to survivorship. On Display in the ASTRO Booth

On display in Varian's ASTRO booth are the company's world-class technologies for external beam radiotherapy, stereotactic radiosurgery, and brachytherapy, including:

-- A new version of RapidArc(TM) radiotherapy technology, which makes it possible to quickly deliver a volumetric intensity-modulated arc treatment with a single rotation of the treatment machine around the patient. New features include multiple and non-coplanar arc treatments for the accurate targeting of large, irregularly shaped, or awkwardly-positioned tumors. (See related press release entitled Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008).

-- The Novalis Tx(TM) image-guided radiosurgery platform, which combines imaging, treatment planning, treatment delivery, and motion management tools from Varian and BrainLAB for the non-invasive treatment of cancer and disorders of the central nervous system. (See related press relea
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related biology technology :

1. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
2. Transgenomic Announces Partnership With Key Genomics for Ovarian Cancer Assay to Guide Therapeutic Options
3. Varian, Inc. Board of Directors Makes Officer Changes
4. National Ovarian Cancer Coalition and PureOlogy to Host First Annual NOCC and PureOlogys Walk to Break the Silence on Ovarian Cancer
5. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
6. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
7. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
8. Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
9. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
10. Varian, Inc. Reports Third Quarter 2008 Results
11. Oncolytics Biotech Inc. Announces Start of Enrolment in Phase 1/2 Ovarian Cancer Clinical Trial with REOLYSIN(R)

Post Your Comments:

(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 ... announced today results from the company sponsore...handra Medical Center in Chennai, India using the ...econstructable Critical Limb Ischemia (CLI). Sri R...ernational-associated institution based in Chennai...

(Date:12/1/2009)..., , SPRINGFIELD, Ill., Dec. 1 /PRNewswire...s proud to announce that it was recently awarded t...ards event on Nov. 13 in New York City. The CLIO H...d innovation in the healthcare advertising industr...he world,s most recognized awards competitions for...

(Date:12/1/2009)..., , CRANBURY, N.J., Dec. 1 /PRNewswire-First...TN ) today announced that the U.S. Patent and Trad... titled "Cyclic Natriuretic Peptide Constructs." ...cyclic compounds that bind to natriuretic peptide ...ad heart failure drug candidate. ,, "Our natriu...

(Date:12/1/2009)..., , SAN FRANCISCO, Dec. 1 /PRNewswire-First...n Board: MZEI) announced today that in tests invol...t continues to break "6 log" decontamination barri...ng bacteria, Claustridium difficile and Bacillis s...re(TM) as an extremely potent sporicidal technolog...

Breaking Biology Technology:Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2 Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3 Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2 Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 2 Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate 3 Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2

[0] Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia [0] Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards [0] Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate [0] Medizone International Takes Aim at the Bioterrorism Countermeasures Arena

...Pharmaceuticals, Inc. (Nasdaq: PPHM ) today anno...Board of Directors, unexpectedly passed away on We...ne since 2004 and was chairman since 2005. At the...s Audit Committee, Compensation Committee and Nomi...ur business colleague and friend Tom Waltz brings ...

...all/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX...exceeded the primary statistical endpoint in its m... intravenous administration of REOLYSIN(R) in pati...to the lung. , "The proportion of patients on st...ul responses is highly encouraging," said Dr. Fran...

...n and Patient-Centered Approach Expected to Drive ... 10 Pharmaceutical Companies in Worldwide Sales, ...Strategy Expands Global Reach and Improves R&D...f Bringing New Medicine to Market from, $1.2...ipeline Boasts Unprecedented 59 Molecules in Clini...

Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz Oncolytics Biotech Inc.'s REOLYSIN(R) Exceeds Primary Statistical Endpoint in U.S. Phase 2 Sarcoma Study Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

(Date:12/2/2009)..., Sally Hall, a PhD student at the University of S...ES) at the National Oceanography Centre, Southampt...of king crab, all from the deep sea. , Hall disc...ons of the National Museum of Natural History in W..., she said: "King crabs include some of the larges...

(Date:12/1/2009)...Researchers at the Yerkes National Primate Researc...rated the first transgenic prairie voles, an impor...pair bonding. The future application of this tech... genetic manipulations that will help identify the...lex social behaviors. This advancement may also ha...

(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...

Breaking Biology News(10 mins):King crab family bigger than ever 2 Yerkes researchers create first transgenic prairie voles 2 New source discovered for the generation of nerve cells in the brain 2 Penn study demonstrates new way to boost immune memory 47936 1 Penn study demonstrates new way to boost immune memory 47936 2 Penn study demonstrates new way to boost immune memory 47936 3 WaveSense Reduces Diabetes Testing Cost by 50 25 47934 1 WaveSense Reduces Diabetes Testing Cost by 50 25 47934 2 Custom Spine Welcomes Randal Clarke as Vice President of Sales 47929 1 Custom Spine Welcomes Randal Clarke as Vice President of Sales 47929 2

[0] King crab family bigger than ever [0] Yerkes researchers create first transgenic prairie voles [2] New source discovered for the generation of nerve cells in the brain

...rong, healthy crops. But until recently, exactly w...s was still a mystery. Scientists from the Flander...) connected to Ghent University have now analyzed ...enes that are essential for the formation of capil...g the genetic basis for the branching of the root ...

...are the first to create a large-scale, cell-based ...ctivate immune-response cells that hold promise fo...ning technique can scan thousands and even million...dritic cells, which are on constant recon patrol t...ted cells and alert the immune system. , "Our ass...

...itoes that helps the insects to fight off infectio... in humans. Anopheles mosquitoes transmit the mala...e each year with these cases resulting in more tha...as identified in a study conducted by a team of in...l of Public Health,s Malaria Research Institute, t...

Other Biology News:Plant genes identified that can form basis for crops better adapted to environmental conditions 2 UT Southwestern researchers develop screening test for cells that activate immune system 2 Gene that helps mosquitoes fight off malaria parasite identified 2

Plant genes identified that can form basis for crops better adapted to environmental conditions UT Southwestern researchers develop screening test for cells that activate immune system Gene that helps mosquitoes fight off malaria parasite identified

Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Unconjugated from R&D Systems

Donor Equine Serum from Equitech-Bio

Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Biotin Conjugated from R&D Systems

Caspase-8 Inhibitor Z-IETD-FMK from BioVision

Biology Products:

Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Unconjugated from R&D Systems Donor Equine Serum from Equitech-Bio Goat Anti-Mouse Aminopeptidase P2 / XPNPEP2 Polyclonal Antibody, Biotin Conjugated from R&D Systems Caspase-8 Inhibitor Z-IETD-FMK from BioVision

Varian Medical Systems Exhibits a New Version of RapidArc(TM) Radiotherapy Technology and Other Products for Fast, Precise Cancer...( Full spectrum of technologies sho...)